guest ::
| Home > Publications database > Spatial immune profiling defines a subset of human gliomas with functional tertiary lymphoid structures. > print |
| Home > Publications database > Spatial immune profiling defines a subset of human gliomas with functional tertiary lymphoid structures. > print |
| 001 | 305509 | ||
| 005 | 20251114105126.0 | ||
| 024 | 7 | _ | |a 10.1016/j.immuni.2025.09.018 |2 doi |
| 024 | 7 | _ | |a pmid:41125076 |2 pmid |
| 024 | 7 | _ | |a 1074-7613 |2 ISSN |
| 024 | 7 | _ | |a 1097-4180 |2 ISSN |
| 024 | 7 | _ | |a altmetric:182727622 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2025-02193 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Cakmak, Pinar |b 0 |
| 245 | _ | _ | |a Spatial immune profiling defines a subset of human gliomas with functional tertiary lymphoid structures. |
| 260 | _ | _ | |a [Cambridge, Mass.] |c 2025 |b Cell Press |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1763113850_499513 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a 2025 Nov 11;58(11):2847-2863.e8 |
| 520 | _ | _ | |a Adult-type diffuse gliomas, the most common primary brain tumors, respond poorly to immune-based therapies and are considered immunologically 'cold' tumors. Here, we examined the features and clinical relevance of glioma intratumoral tertiary lymphoid structures (TLSs) using spatial transcriptome and proteome profiling. In a cohort of 642 gliomas, TLSs were present in 15% of tumors and associated with a remodeled perivascular space and spatial redistribution of extracellular matrix components. Three distinct TLS subtypes could be defined based on differing cellular composition and immune activity. While all subtypes lacked classical germinal center architecture, certain TLSs exhibited features of dynamic immune functions, including clonal T and B cell expansion, generation of IgA⁺ and IgG⁺ plasma cells, and dendritic cell-T cell interactions. The presence of TLSs with active immune response features correlated with improved overall survival. Thus, a functional adaptive immune response is detectable in some gliomas, with implications for stratification and treatment. |
| 536 | _ | _ | |a 899 - ohne Topic (POF4-899) |0 G:(DE-HGF)POF4-899 |c POF4-899 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
| 650 | _ | 7 | |a B cells |2 Other |
| 650 | _ | 7 | |a adaptive immune receptor repertoire |2 Other |
| 650 | _ | 7 | |a adult-type diffuse glioma |2 Other |
| 650 | _ | 7 | |a blood-brain barrier |2 Other |
| 650 | _ | 7 | |a glioblastoma |2 Other |
| 650 | _ | 7 | |a immune aggregate |2 Other |
| 650 | _ | 7 | |a spatial molecular profiling |2 Other |
| 650 | _ | 7 | |a spatial transcriptomics |2 Other |
| 650 | _ | 7 | |a tertiary lymphoid structures |2 Other |
| 650 | _ | 7 | |a tumor immunology |2 Other |
| 700 | 1 | _ | |a Lun, Jennifer H |b 1 |
| 700 | 1 | _ | |a Singh, Aakanksha |b 2 |
| 700 | 1 | _ | |a Macas, Jadranka |b 3 |
| 700 | 1 | _ | |a Schupp, Jonathan |b 4 |
| 700 | 1 | _ | |a Schuck, Jonas |b 5 |
| 700 | 1 | _ | |a Mahmoud, Zeina |b 6 |
| 700 | 1 | _ | |a Köhler, Miriam |b 7 |
| 700 | 1 | _ | |a Starzetz, Tatjana |b 8 |
| 700 | 1 | _ | |a Burger, Michael C |b 9 |
| 700 | 1 | _ | |a Steidl, Eike |0 P:(DE-HGF)0 |b 10 |
| 700 | 1 | _ | |a Hasse, Lucie Marie |b 11 |
| 700 | 1 | _ | |a Hattingen, Elke |0 P:(DE-HGF)0 |b 12 |
| 700 | 1 | _ | |a Plate, Karl H |0 P:(DE-HGF)0 |b 13 |
| 700 | 1 | _ | |a Reiss, Yvonne |0 P:(DE-HGF)0 |b 14 |
| 700 | 1 | _ | |a Imkeller, Katharina |b 15 |
| 773 | _ | _ | |a 10.1016/j.immuni.2025.09.018 |g p. S1074761325004297 |0 PERI:(DE-600)2001966-X |n 11 |p 2847-2863.e8 |t Immunity |v 58 |y 2025 |x 1074-7613 |
| 909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:305509 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 10 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 12 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 13 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 14 |6 P:(DE-HGF)0 |
| 913 | 1 | _ | |a DE-HGF |b Programmungebundene Forschung |l ohne Programm |1 G:(DE-HGF)POF4-890 |0 G:(DE-HGF)POF4-899 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-800 |4 G:(DE-HGF)POF |v ohne Topic |x 0 |
| 914 | 1 | _ | |y 2025 |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2025-01-01 |w ger |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b IMMUNITY : 2022 |d 2025-01-01 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2025-01-01 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2025-01-01 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2025-01-01 |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2025-01-01 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2025-01-01 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2025-01-01 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2025-01-01 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2025-01-01 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2025-01-01 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2025-01-01 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2025-01-01 |
| 915 | _ | _ | |a IF >= 30 |0 StatID:(DE-HGF)9930 |2 StatID |b IMMUNITY : 2022 |d 2025-01-01 |
| 920 | 1 | _ | |0 I:(DE-He78)FM01-20160331 |k FM01 |l DKTK Koordinierungsstelle Frankfurt |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)FM01-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|